Teva pharmaceutical
Index Globenewswire
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
Rabu, 24 Desember 2025 - 21:43:13 Wib Globenewswire
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
Jumat, 19 Desember 2025 - 23:24:52 Wib Globenewswire
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
Sabtu, 13 Desember 2025 - 18:19:12 Wib Globenewswire
Teva Receives European Commission Approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®
Rabu, 26 November 2025 - 04:34:43 Wib Globenewswire
Teva's Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS
Kamis, 06 November 2025 - 03:32:51 Wib Globenewswire
Teva Kicks Off ‘The Other TD’ to Raise Awareness of Tardive Dyskinesia (TD), with Support from Pro Football Hall of Famer Terrell Davis
Senin, 03 November 2025 - 21:44:06 Wib Globenewswire
Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November
Ahad, 02 November 2025 - 01:12:03 Wib Globenewswire
Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe
Rabu, 22 Oktober 2025 - 02:44:29 Wib Globenewswire
Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025
Sabtu, 27 September 2025 - 02:45:20 Wib Globenewswire
Patients Taking AUSTEDO XR® (deutetrabenazine) Extended-release Tablets Reported Symptom Improvement and High Satisfaction
Senin, 22 September 2025 - 02:25:11 Wib Berita
Teva’s Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy
Rabu, 10 September 2025 - 04:08:15 Wib Globenewswire
Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September
Rabu, 03 September 2025 - 23:16:09 Wib Globenewswire
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss
Kamis, 28 Agustus 2025 - 22:10:36 Wib Globenewswire
FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine
Kamis, 07 Agustus 2025 - 00:14:16 WibTerpopuler
Index
1
Dandim Dumai Laksanakan Pengawasan Program Dapur Makan Bergizi
Dibaca: 102 Kali
2
3
4
